Clinical Trials Directory

Trials / Conditions / Metastatic Adrenal Gland Pheochromocytoma

Metastatic Adrenal Gland Pheochromocytoma

7 registered clinical trials studyying Metastatic Adrenal Gland Pheochromocytoma.

StatusTrialSponsorPhase
Active Not RecruitingTesting the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Ne
NCT04394858
National Cancer Institute (NCI)Phase 2
WithdrawnRadioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endo
NCT04106843
M.D. Anderson Cancer CenterPhase 2
WithdrawnVeliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine
NCT02831179
Vanderbilt-Ingram Cancer CenterPhase 1
CompletedLenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be R
NCT03008369
Mayo ClinicPhase 2
Active Not RecruitingPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
NCT02721732
M.D. Anderson Cancer CenterPhase 2
CompletedCabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be
NCT02302833
M.D. Anderson Cancer CenterPhase 2
TerminatedPazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraga
NCT01340794
National Cancer Institute (NCI)Phase 2